4.3 Article

The Role of Notch3 Signaling in Kidney Disease

Journal

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
Volume 2020, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2020/1809408

Keywords

-

Categories

Funding

  1. Fundamental Research Funds for Central University [2042020kf0137]
  2. Zhongnan Hospital of Wuhan University Science, Technology, and Innovation Seed Fund [znpy2017044, znpy2019036]
  3. Hubei Province Health and Family Planning Scientific Research Project [WJ2019MB103]
  4. Clinical Research Project for Wu Jieping Medical Foundation [320.6750.19089-58]
  5. Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University [PTXM2020028]

Ask authors/readers for more resources

Notch receptors are transmembrane proteins that are members of the epidermal growth factor-like family. These receptors are widely expressed on the cell surface and are highly conserved. Binding to ligands on adjacent cells results in cleavage of these receptors, and their intracellular domains translocate into the nucleus, where target gene transcription is initiated. In the mammalian kidney, Notch receptors are activated during nephrogenesis and become silenced in the normal kidney after birth. Reactivation of Notch signaling in the adult kidney could be due to the genetic activation of Notch signaling or kidney injury. Notch3 is a mammalian heterodimeric transmembrane receptor in the Notch gene family. Notch3 activation is significantly increased in various glomerular diseases, renal tubulointerstitial diseases, glomerular sclerosis, and renal fibrosis and mediates disease occurrence and development. Here, we discuss numerous recently published papers describing the role of Notch3 signaling in kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available